Rockwell Medical (RMTI) Change in Receivables (2010 - 2026)
Rockwell Medical (RMTI) reported Change in Receivables of $682000.0 for Q1 2026, down 50.54% on a YoY basis from $1.4 million in Q1 2025, and up 1018.03% quarter-over-quarter from $61000.0 in Q4 2025.
Rockwell Medical (RMTI) Change in Receivables (2010 - 2026) Analysis & Trends
Rockwell Medical has reported Change in Receivables for 17 years, with the latest figure at $682000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 50.54% year-over-year to $682000.0; the trailing twelve-month figure through Mar 2026 stood at -$599000.0 (up 57.94% YoY), and the FY2025 full-year result was $98000.0, up 103.75% from the prior year.
- Change in Receivables for Q1 2026 stood at $682000.0, up from $61000.0 in the prior quarter.
- The five-year high for Change in Receivables was $4.0 million in Q3 2023, with the low at -$2.0 million in Q3 2024.
- Historically, Change in Receivables has averaged $185764.7 across 5 years, with a median of $61000.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Receivables plunged 800.81% — and 2023, when it jumped 646.33%.
- Rockwell Medical's Change in Receivables stood at -$1.1 million in 2022, then soared by 238.99% to $1.5 million in 2023, then slumped by 138.05% to -$586000.0 in 2024, then jumped by 110.41% to $61000.0 in 2025, then jumped by 1018.03% to $682000.0 in 2026.
- The last three Change in Receivables figures came in at $682000.0 (Q1 2026), $61000.0 (Q4 2025), and $244000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.23 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 116.25 Mn |
| 10 | Rockwell Medical | 26.01 Mn | 2.12 Mn | 2.90 Mn | 682,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 682,000.00 |
| Mar 31, 2026 | 682,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Dec 31, 2025 | 61,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Jun 30, 2025 | -1.59 Mn |
| Jun 30, 2025 | -1.59 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | -586,000.00 |
| Dec 31, 2024 | -586,000.00 |
| Sep 30, 2024 | -1.96 Mn |
| Sep 30, 2024 | -1.96 Mn |
| Jun 30, 2024 | -254,000.00 |
| Jun 30, 2024 | -254,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Mar 31, 2024 | 193,000.00 |
| Dec 31, 2023 | 1.54 Mn |
| Dec 31, 2023 | 1.54 Mn |